News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
The GlaxoSmithKline-Gilead HIV Battle Could Be Epic
December 29, 2016
·
1 min read
Biotech Bay
Will 2017 Be Gilead’s Worst Year Yet?
December 27, 2016
·
1 min read
Biotech Bay
These 3 Biotech Stocks Are Better Buys Than Gilead
December 22, 2016
·
3 min read
Biotech Bay
Gilead Has Bought Back $10 Billion Of Stock In 2016. Should Investors Be Happy?
December 20, 2016
·
1 min read
Biotech Bay
Here’s Why Amgen, Celgene, and Gilead Like These Small Biotechs
December 19, 2016
·
2 min read
Biotech Bay
Gilead’s Best Moves and Biggest Mistake in 2016
December 16, 2016
·
1 min read
Policy
Gilead Sinks, Will Pay Rival $2.54 Billion for a Patent Dispute
December 16, 2016
·
2 min read
Biotech Bay
How You Could Get Gilead to Help You Make $30,000 a Year in Retirement
December 12, 2016
·
2 min read
Biotech Bay
Gilead CEO Remorseful Over Sovaldi’s $1,000 Per Pill Price Tag
December 8, 2016
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
Gilead Release: Phase 2 Data For Selonsertib In Nonalcoholic Steatohepatitis (NASH) Presented At The Liver Meeting 2016
November 15, 2016
·
6 min read
Biotech Bay
European CHMP Adopts Positive Opinion For Gilead’s Vemlidy (Tenofovir Alafenamide, TAF) For The Treatment Of Chronic Hepatitis B Virus Infection
November 11, 2016
·
3 min read
FDA
FDA Approves Gilead’s Vemlidy (Tenofovir Alafenamide) For The Treatment Of Chronic Hepatitis B Virus Infection
November 10, 2016
·
8 min read
Drug Development
Investors Hold Their Breath for Gilead’s Late-Stage Myelofibrosis Data
November 9, 2016
·
1 min read
Business
Gilead Announces Third Quarter 2016 Financial Results
November 2, 2016
·
1 min read
Business
Nimbus Therapeutics Announces $200 Million Milestone Payment From Gilead For Allosteric ACC Inhibitor Program In Non-alcoholic Steatohepatitis (NASH)
November 2, 2016
·
3 min read
Business
Gilead To Release Third Quarter 2016 Financial Results On Tuesday, November 1, 2016
October 26, 2016
·
1 min read
Drug Development
Gilead Presents Results From Phase 3 Studies Evaluating Switching To Descovy (FTC/TAF)-Based Regimens From Truvada (FTC/TDF)-Based Regimens
October 24, 2016
·
1 min read
Drug Development
Gilead Touts 2-Year Late-Stage Descovy-Truvada HIV Data
October 24, 2016
·
19 min read
Policy
Gilead Asks FDA To Expand Exclusivity For A Key HIV Drug
October 21, 2016
·
1 min read
